{
    "id": 25331,
    "fullName": "IGF1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "IGF1 over exp indicates an over expression of the Igf1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3479,
        "geneSymbol": "IGF1",
        "terms": [
            "IGF1",
            "IGF",
            "IGF-I",
            "IGFI",
            "MGF"
        ]
    },
    "variant": "over exp",
    "createDate": "09/13/2016",
    "updateDate": "02/13/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8339,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MEDI-573 inhibited IGF signaling and growth of Ewing sarcoma cell lines with high levels of IGF1 in culture, and inhibited tumor growth in IGF1-expressing Ewing sarcoma cell line xenograft models (PMID: 25193511).",
            "molecularProfile": {
                "id": 26236,
                "profileName": "IGF1 over exp"
            },
            "therapy": {
                "id": 4708,
                "therapyName": "MEDI-573",
                "synonyms": null
            },
            "indication": {
                "id": 3369,
                "name": "Ewing sarcoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6622,
                    "pubMedId": 25193511,
                    "title": "MEDI-573, alone or in combination with mammalian target of rapamycin inhibitors, targets the insulin-like growth factor pathway in sarcomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25193511"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26236,
            "profileName": "IGF1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}